See more : Softmax Co., Ltd (3671.T) Income Statement Analysis – Financial Results
Complete financial analysis of Doctor Care Anywhere Group PLC (DOC.AX) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Doctor Care Anywhere Group PLC, a leading company in the Medical – Healthcare Information Services industry within the Healthcare sector.
- PSB Industries (PSB.PA) Income Statement Analysis – Financial Results
- Mud & Hound Public Company Limited (MUD.BK) Income Statement Analysis – Financial Results
- Impex Ferro Tech Limited (IMPEXFERRO.BO) Income Statement Analysis – Financial Results
- Komatsu Wall Industry Co., Ltd. (7949.T) Income Statement Analysis – Financial Results
- Lobe Sciences Ltd. (LOBE.CN) Income Statement Analysis – Financial Results
Doctor Care Anywhere Group PLC (DOC.AX)
Industry: Medical - Healthcare Information Services
Sector: Healthcare
Website: https://www.doctorcareanywhere.com
About Doctor Care Anywhere Group PLC
Doctor Care Anywhere Group PLC, together with its subsidiaries, provides digital healthcare and development services in the United Kingdom, Australia, and the Republic of Ireland. It offers services in the areas of appointments, patient records, prescriptions, referrals and fit notes, service improvements, and virtual GP consultations in the form of video and phone. The company provides treatments for allergies, bites and stings, cold and flu, headaches and migraines, joint pains, lifestyle support, mental and sexual health, skin conditions, and stomach and digestive problems, as well as offers virtual healthcare, technology platform licensing, and digital design services. It serves medical insurers, employers, retailers, healthcare providers, and direct sales to the public. The company was incorporated in 2013 and is headquartered in London, the United Kingdom.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 38.46M | 30.42M | 13.74M | 9.92M | 5.76M |
| Cost of Revenue | 20.77M | 17.00M | 7.82M | 3.31M | 2.31M |
| Gross Profit | 17.69M | 13.42M | 5.92M | 6.61M | 3.45M |
| Gross Profit Ratio | 46.00% | 44.12% | 43.06% | 66.62% | 59.90% |
| Research & Development | 0.00 | 7.35M | 2.60M | 1.23M | 1.29M |
| General & Administrative | 22.36M | 23.78M | 12.41M | 9.37M | 0.00 |
| Selling & Marketing | 709.00K | 1.86M | 1.82M | 904.40K | 0.00 |
| SG&A | 23.07M | 25.64M | 14.23M | 10.27M | 6.65M |
| Other Expenses | -5.38M | 625.00K | 0.00 | 3.40M | 0.00 |
| Operating Expenses | 17.69M | 32.99M | 16.83M | 11.50M | 7.94M |
| Cost & Expenses | 46.86M | 49.99M | 24.65M | 14.81M | 10.25M |
| Interest Income | 25.89K | 1.00K | 1.07K | 0.00 | 1.01K |
| Interest Expense | 507.00K | 77.00K | 76.80K | 12.31M | 21.14K |
| Depreciation & Amortization | -187.00K | 3.68M | 1.37M | 946.16K | 934.34K |
| EBITDA | -8.35M | -22.21M | -10.95M | -5.35M | -4.84M |
| EBITDA Ratio | -21.72% | -64.81% | -79.67% | -53.96% | -61.61% |
| Operating Income | -8.17M | -19.57M | -10.99M | -17.21M | -4.49M |
| Operating Income Ratio | -21.23% | -64.34% | -79.94% | -173.49% | -77.82% |
| Total Other Income/Expenses | -694.00K | -2.09M | -40.28K | -9.37M | -1.31M |
| Income Before Tax | -8.86M | -22.29M | -11.03M | -17.66M | -5.80M |
| Income Before Tax Ratio | -23.04% | -73.28% | -80.23% | -178.11% | -100.58% |
| Income Tax Expense | -695.00K | -257.00K | -168.11K | -50.68K | -83.57K |
| Net Income | -10.05M | -22.03M | -10.86M | -17.61M | -5.71M |
| Net Income Ratio | -26.13% | -72.43% | -79.01% | -177.60% | -99.13% |
| EPS | -0.03 | -0.06 | -0.03 | -0.10 | -0.02 |
| EPS Diluted | -0.03 | -0.06 | -0.03 | -0.10 | -0.02 |
| Weighted Avg Shares Out | 366.67M | 360.50M | 322.36M | 171.86M | 318.37M |
| Weighted Avg Shares Out (Dil) | 366.67M | 360.50M | 322.36M | 171.86M | 318.37M |
Source: https://incomestatements.info
Category: Stock Reports